Drug Treatment of Ischemic Heart Disease Fixed "Stable" Angina Variant Angina Unstable Angina...
-
Upload
marion-wilson -
Category
Documents
-
view
238 -
download
5
Transcript of Drug Treatment of Ischemic Heart Disease Fixed "Stable" Angina Variant Angina Unstable Angina...
Drug Treatment of Drug Treatment of Ischemic Heart Ischemic Heart
DiseaseDiseaseFixed "Stable" AnginaFixed "Stable" Angina
Variant AnginaVariant Angina
Unstable AnginaUnstable Angina
Myocardial InfarctionMyocardial Infarction
Mechanism of AnginaMechanism of Angina
OO22 Supply (Coronary Blood Supply (Coronary Blood Flow)Flow)
OO22 Demand (Work of the Demand (Work of the Heart) Heart)
Secondary AnginaSecondary Angina Primary AnginaPrimary Angina
ClassicalClassical Variant Variant (Prinzmetal’s) (Prinzmetal’s)
Angina of EffortAngina of Effort Angina at RestAngina at Rest
TypicalTypical AtypicalAtypical
17681768 19571957
Small vesselsSmall vessels Large vesselsLarge vessels
Single or multipleSingle or multiple SingleSingle
AtherosclerosisAtherosclerosis VasospasmVasospasm
ST depressionST depression ST elevationST elevation
Control of vascular smooth muscle Control of vascular smooth muscle contractioncontraction
Organic NitratesOrganic Nitrates
►Nitroglycerine (GTN):Nitroglycerine (GTN):►Prototype, used for more than 125 Prototype, used for more than 125
years.years.►Nonspecific smooth muscle Nonspecific smooth muscle
relaxant.relaxant.►Action not antagonized by any Action not antagonized by any
known antagonist.known antagonist.
Mechanism of action of nitrates, nitrites, and other Mechanism of action of nitrates, nitrites, and other substances that increase the concentration of nitric oxide substances that increase the concentration of nitric oxide
(NO) in vascular muscle(NO) in vascular muscle
Nitroglycerine (GTN)Nitroglycerine (GTN)►Usually administered sublingually.Usually administered sublingually.►Can be administered by various Can be administered by various
routes.routes.►Fast onset of action(1-Fast onset of action(1-
3minutes,Peaks at 10 minutes). 3minutes,Peaks at 10 minutes). ►Short duration (15-30minutes).Short duration (15-30minutes).►Reductase enzyme in liver will Reductase enzyme in liver will
breakdown the drug. breakdown the drug.
Nitroglycerine (GTN)Nitroglycerine (GTN)
►Causes general vasodilation:Causes general vasodilation:►Arteriolar dilationArteriolar dilation: short lived (5-10 : short lived (5-10
min)min)►Will decrease systemic blood Will decrease systemic blood
pressure (afterload) and cause reflex pressure (afterload) and cause reflex tachycardia and increased tachycardia and increased contractility, ?might increase MVO2.contractility, ?might increase MVO2.
►Venous dilationVenous dilation: more intense, even : more intense, even with low doses, lasts for 30 minutes, with low doses, lasts for 30 minutes, decreases venous return (preload) decreases venous return (preload) and decreases MVO2. and decreases MVO2.
Beneficial and Deleterious Effects of Nitrates in the Treatment of Beneficial and Deleterious Effects of Nitrates in the Treatment of Angina.Angina.
EffectEffect ResultResult
Potential beneficial effectsPotential beneficial effects
Decreased ventricular volumeDecreased ventricular volume Decreased myocardial oxygen Decreased myocardial oxygen requirementrequirement
Decreased arterial pressureDecreased arterial pressure
Decreased ejection timeDecreased ejection time
Vasodilation of epicardial coronary Vasodilation of epicardial coronary arteriesarteries
Relief of coronary artery Relief of coronary artery spasmspasm
Increased collateral flowIncreased collateral flow Improved perfusion to Improved perfusion to ischemic myocardiumischemic myocardium
Decreased left ventricular diastolic Decreased left ventricular diastolic pressurepressure
Improved subendocardial Improved subendocardial perfusionperfusion
Potential deleterious effects Potential deleterious effects
Reflex tachycardiaReflex tachycardia Increased myocardial oxygen Increased myocardial oxygen requirementrequirement
Reflex increase in contractilityReflex increase in contractility
Decreased diastolic perfusion time Decreased diastolic perfusion time due to tachycardiadue to tachycardia
Decreased coronary perfusionDecreased coronary perfusion
Nitroglycerine (GTN)Nitroglycerine (GTN)►Side Effects:Side Effects:►Headache.Headache.►Hypotension and tachycardia.Hypotension and tachycardia.► Increased intraocular and intracranial Increased intraocular and intracranial
pressures.pressures.►Methemoglobinemia.Methemoglobinemia.► Tolerance: only for the arteriolar effects.Tolerance: only for the arteriolar effects.►Withdrawal: in workers in ammunition Withdrawal: in workers in ammunition
industry.industry.
Nitrate and Nitrite Drugs Used in the Treatment of Angina.Nitrate and Nitrite Drugs Used in the Treatment of Angina.
DrugDrug Duration of ActionDuration of Action
Short-acting: Short-acting:
Nitroglycerin, sublingualNitroglycerin, sublingual 10–30 minutes10–30 minutes
Isosorbide dinitrate, Isosorbide dinitrate, sublingualsublingual
10–60 minutes10–60 minutes
Amyl nitrite, inhalantAmyl nitrite, inhalant 3–5 minutes3–5 minutes
Long-acting: Long-acting:
Nitroglycerin, oral sustained-Nitroglycerin, oral sustained-actionaction
6–8 hours6–8 hours
Nitroglycerin, 2%Nitroglycerin, 2% ointment ointment, , transdermaltransdermal
3–6 hours3–6 hours
Nitroglycerin, slow-release, Nitroglycerin, slow-release, buccalbuccal
3–6 hours3–6 hours
Nitroglycerin, Nitroglycerin, slow-release slow-release patchpatch, transdermal, transdermal
8–10 hours8–10 hours
Isosorbide dinitrate, Isosorbide dinitrate, sublingualsublingual
1.5–2 hours1.5–2 hours
Isosorbide dinitrate, oralIsosorbide dinitrate, oral 4–6 hours4–6 hours
Isosorbide dinitrate, Isosorbide dinitrate, chewable oralchewable oral
2–3 hours2–3 hours
Isosorbide mononitrate, oralIsosorbide mononitrate, oral 6–10 hours6–10 hours
Beta Adrenergic BlockersBeta Adrenergic Blockers►Prevent actions of catecholamines, Prevent actions of catecholamines,
so more effective during exertion.so more effective during exertion.►No increase in collateral blood flow.No increase in collateral blood flow.►Cause subjective and objective Cause subjective and objective
improvement: decreased number of improvement: decreased number of anginal episodes, nitroglycerine anginal episodes, nitroglycerine consumption, enhanced exercise consumption, enhanced exercise tolerance, and improved ECG.tolerance, and improved ECG.
Beta Adrenergic BlockersBeta Adrenergic Blockers
Calcium Channel BlockersCalcium Channel Blockers
Particularly beneficial in Particularly beneficial in vasospasm.vasospasm.
Can affect platelets aggregation. Can affect platelets aggregation.
May be dangerous in heart failure May be dangerous in heart failure and in patients susceptible to and in patients susceptible to hypotension.hypotension.
Properties of Several Recognized Voltage-Activated Calcium Channels.Properties of Several Recognized Voltage-Activated Calcium Channels.
TypTypee
Channel Channel NameName
Where FoundWhere Found Properties Properties of the of the Calcium Calcium CurrentCurrent
Blocked Blocked ByBy
LL CaCaVV1.1–1.1–
CaCaVV1.31.3
Cardiac, skeletal, smooth Cardiac, skeletal, smooth muscle, neurons (Camuscle, neurons (CaVV1.4 is 1.4 is
found in retina), endocrine found in retina), endocrine cells, bonecells, bone
Long, large, Long, large, high high thresholdthreshold
Verapamil, Verapamil, DHPs, CdDHPs, Cd2+2+, , -aga-IIIA -aga-IIIA
TT CaCaVV3.1–3.1–
CaCaVV3.33.3
Heart, neuronsHeart, neurons Short, small, Short, small, low thresholdlow threshold
sFTX, sFTX, flunarizine, flunarizine, NiNi2+2+, , mibefradilmibefradil11
NN CaCaVV2.22.2
Neurons, spermNeurons, sperm22
Short, high Short, high thresholdthreshold
Ziconotide,Ziconotide,33 gabapenti gabapentin,n,44 -CTX- -CTX-GVIA, -GVIA, -aga-IIIA, aga-IIIA, CdCd2+2+
P/QP/Q CaCaVV2.12.1
NeuronsNeurons Long, high Long, high
thresholdthreshold -CTX--CTX-MVIIC, -MVIIC, -aga-IVAaga-IVA
RR CaCaVV2.32.3
Neurons, spermNeurons, sperm22
PacemakingPacemaking SNX-482, SNX-482,
-aga-IIIA -aga-IIIA
Calcium Channel BlockersCalcium Channel Blockers
►Side Effects:Side Effects:►Hypotension.Hypotension.►Headache, dizziness.Headache, dizziness.►Flushing.Flushing.►Peripheral edema.Peripheral edema.
Effects of Nitrates Alone and with Beta Blockers or Calcium Effects of Nitrates Alone and with Beta Blockers or Calcium Channel Blockers in Angina Pectoris. Channel Blockers in Angina Pectoris.
Nitrates Nitrates AloneAlone
Beta Blockers or Beta Blockers or Calcium Channel Calcium Channel BlockersBlockers
Combined Nitrates with Combined Nitrates with Beta Blockers or Calcium Beta Blockers or Calcium Channel BlockersChannel Blockers
Heart Heart raterate
ReflexReflex11increaseincrease
DecreaseDecrease
DecreaseDecrease
Arterial Arterial pressurepressure
DecreaseDecrease DecreaseDecrease DecreaseDecrease
End-End-diastolic diastolic volumevolume
DecreaseDecrease IncreaseIncrease None or decreaseNone or decrease
ContractilitContractilityy
ReflexReflex11increaseincrease
DecreaseDecrease NoneNone
Ejection Ejection timetime
Decrease1Decrease1 IncreaseIncrease NoneNone
DipyridamoleDipyridamole►Inhibits the uptake of adenosine Inhibits the uptake of adenosine and inhibits adenosine and inhibits adenosine deaminase enzyme.deaminase enzyme.
►Thought to be a good coronary Thought to be a good coronary dilator.dilator.
►Increases the blood flow to the Increases the blood flow to the normal area i.e.normal area i.e.“Coronary Steal “Coronary Steal Phenomenon”.Phenomenon”.
►Still used as an antiplatelet drug Still used as an antiplatelet drug (in TIAs), but not better than (in TIAs), but not better than aspirin. aspirin.
OthersOthers ►ACEI.ACEI.
►Anticoagulants and/or Anticoagulants and/or Thrombolytic Therapy.Thrombolytic Therapy.
►Cholesterol Lowering Agents.Cholesterol Lowering Agents.
►AngioplastyAngioplasty
►Surgery.Surgery.
Newer Antianginal Drugs Newer Antianginal Drugs ►Metabolic modulators: Ranolazine.Metabolic modulators: Ranolazine.►Direct bradycardic agents: Ivabradine.Direct bradycardic agents: Ivabradine.►Potassium channel activators: Potassium channel activators:
Nicorandil.Nicorandil.►Rho-kinase inhibitors: Fasudil.Rho-kinase inhibitors: Fasudil.►Sulfonylureas: Glibenclamide.Sulfonylureas: Glibenclamide.►Thiazolidinediones.Thiazolidinediones.►Vasopeptidase inhibitors.Vasopeptidase inhibitors.►Nitric oxide donors: L- arginine.Nitric oxide donors: L- arginine.►Capsaicin.Capsaicin.►Amiloride.Amiloride.